NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)

NCT03927820

CompletedNA

Sponsor: Vanderbilt University Medical Center

Conditions: COPD, Asthma

Interventions: Benefits investigation

Countries: United States

The goal of this study is to assess the impact of pharmacist-led benefits investigations and application of clinical practice guidelines on patient access to inhalers and time to hospital readmission or Emergency Department (ED) visit.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Adult patient admitted to Vanderbilt University Medical Center (VUMC) (excluding surgery services)
* on a long acting inhaler or prescribed a long acting inhaler during admission.

Exclusion Criteria:

* Diagnosis of cystic fibrosis
* Diagnosis of graft versus host disease (GVHD)
* no medication insurance
* discharge to any post-acute care facility or inpatient hospice
* death during hospitalization
Locations (1)
  • Nashville, Tennessee, United States